One study compared consecutive BC series from Switzerland and Saudi Arabia between 1988 and 2002 and reported a 31% frequency of HER2 amplification in Saudi Arabian BCs, which was significantly higher than that reported in the Swiss samples (17%) [13]. Here, ERBB2 is linked to breast cancer.